CYTH Past Earnings image   This CYTH past earnings page last updated 3/21/2023
CYTH Past Earnings
PeriodPast Earnings DateGAAP
Q4 20223/20/2023-0.590
Q3 202211/11/2022-0.500
Q2 20228/16/2022-0.410
Q1 20225/12/2022-0.310
Q4 20213/11/2022-0.340
Q3 202111/15/2021-0.600
Q2 20218/16/2021-0.560
Q1 20215/17/2021-0.760
Q4 20203/15/2021-1.680
CYTH Past Revenue
PeriodPast Earnings DateGAAP
Q4 20223/20/20230.00B
Q3 202211/11/20220.00B
Q2 20228/16/20220.00B
Q1 20225/12/20220.00B
Q4 20213/11/20220.00B
Q3 202111/15/20210.00B
Q2 20218/16/20210.00B
Q1 20215/17/20210.00B
Q4 20203/15/20210.00B
Quotes delayed 20 minutes

Email EnvelopeFree CYTH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cyclo Therapeutics (CYTH) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CYTK Past Earnings
DARE Past Earnings
DAWN Past Earnings
DBTX Past Earnings
DCGO Past Earnings
DCPH Past Earnings
DCTH Past Earnings
DERM Past Earnings
DFFN Past Earnings
DGX Past Earnings

CYTH Past Earnings Q&A

What was the best and worst CYTH past earnings results?
For Cyclo Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CYTH past earnings result in our data set was -0.310/share posted in Q1 2022, while the lowest was in Q4 2020 when CYTH posted -1.680/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when CYTH reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q4 2020 at 0.00B of revenue.

  Suggested answer: There are 9 CYTH past earnings results in our data set.

On this page we presented the CYTH past earnings date information for Cyclo Therapeutics. Reviewing that CYTH Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2022, when CYTH posted gaap of -0.310/share. Meanwhile the lowest CYTH past earnings result was in Q4 2020, when CYTH posted gaap of -1.680/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when CYTH reported 0.00B in revenue, while the smallest revenue quarter was Q4 2020 when CYTH reported 0.00B in revenue.

Any self directed investor doing their due diligence on CYTH or any other given stock can benefit from researching all of the Cyclo Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Cyclo Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CYTH. Thanks for visiting, and the next time you need to research CYTH past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: AOK Dividend History, ETFs Holding MGA, OGI Options Chain.


CYTH Past Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.